Oncofactor

company

About

Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$2.10M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Oncofactor is a Seattle, Washington-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$2.10M
Oncofactor has raised a total of $2.10M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2011 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2011 Series A $2.10M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Oncofactor is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series A